Cart
sales@molnova.com
ATG7-IN-1
CAS No. 2226229-87-2
ATG7-IN-1( —— )
Catalog No. M35143 CAS No. 2226229-87-2
ATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 500 | Get Quote |
|
| 5MG | 758 | Get Quote |
|
| 10MG | 1036 | Get Quote |
|
| 25MG | 1518 | Get Quote |
|
| 50MG | 2052 | Get Quote |
|
| 100MG | 2637 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameATG7-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
-
DescriptionATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2226229-87-2
-
Formula Weight470.5
-
Molecular FormulaC17H19FN6O5S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(C=1C=2C(N(N1)[C@@H]3O[C@@H](COS(N)(=O)=O)[C@@H](O)C3)=NC=NC2N)C4=C(F)C=C(C)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
UVI 3003
UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
-
Indole-3-Glyoxylyl C...
It is an organic compunds with molecular fomula C10H6ClNO2.
